Indian Government Directs Air India to Enhance Drug Testing Protocols

The Indian government has taken a decisive stance following a recent incident involving an Air India pilot who tested positive for cannabis. On August 4, the pilot of a Phuket-Delhi flight experienced significant altitude loss, which injured several passengers. This incident has prompted officials to call for stricter drug testing protocols within the aviation sector.

Air India is being urged to implement a system of accountability in response to this situation, while the Directorate General of Civil Aviation (DGCA) has been directed to enhance existing drug testing procedures for pilots. The DGCA, which oversees civil aviation regulations in India, is expected to address the issues raised in light of this event.

According to reports, during questioning by investigators from the Aircraft Accident Investigation Bureau (AAIB), the pilot disclosed that he had struggled with sleep issues related to personal circumstances, and he had been taking prescribed medication. Despite this, he did not provide the specifics regarding the medication used. Under DGCA regulations, pilots are required to disclose any prescription medications to their airline; failure to do so could lead to disciplinary action.

Post-flight drug tests revealed that the pilot’s initial screening was marked as "non-negative," indicating the need for further analysis. The confirmatory tests subsequently returned a positive result for cannabis. During the flight, it was reported that the pilot slept approximately 30 to 35 minutes, and during his time in the cockpit, a sudden altitude loss occurred. The first officer, who was piloting the aircraft at the time, assisted the commander when the latter was thrown to the cockpit floor following a turbulence incident.

This case has raised serious concerns regarding pilot health and safety management in the Indian aviation industry. The DGCA's response to these newfound challenges will be closely monitored, as the safety of air travel remains a paramount concern for regulators and passengers alike.

This incident comes as Air India has faced scrutiny previously regarding operational standards. The recent events may push the airline to reconsider its internal policies about pilot health and medication disclosures to ensure that they are in line with regulatory requirements and best practices in aviation safety. Further investigations are ongoing, with detailed reports expected from the DGCA and Air India in the near future.